Backbone Cyclization of the C-terminal Part of Substance P. Part 1: The Important Role of the Sulphur in Position 11

被引:14
作者
Bitan, Gal [1 ,2 ]
Zeltser, Irena [1 ,2 ]
Byk, Gerardo [1 ,2 ]
Halle, David [1 ,2 ]
Mashriki, Yaffa [3 ]
Gluhov, Evgenia V. [1 ,2 ]
Sukhotinsky, Inna [1 ,2 ]
Hanani, Menachem [3 ]
Selinger, Zvi [1 ,2 ]
Gilon, Chaim [1 ,2 ]
机构
[1] Hebrew Univ Jerusalem, Dept Organ Chem, IL-91904 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel
[3] Hadassah Univ Hosp, Lab Expt Surg, IL-91120 Jerusalem, Israel
关键词
substance P; agonist; conformational constraint; backbone cyclization;
D O I
10.1002/psc.76
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel backbone-to-side chain and backbone-to-backbone cyclic analogues of substance P (SP) were prepared by solid-phase synthesis and screened for biological activity. An analogue containing a thioetherlactam ring between positions 9 and 1 1 showed an EC50 value of 20 nM toward the neurokinin 1 (NK-1) and was inactive toward the NK-2 and NK-3 receptors. On the other hand, in a multiple backbone cyclic peptide library of similar analogues, in which the sulphur was excluded from the ring, very low activity was detected. The activity was re-evaluated and was found to be even lower (EC50 = 0.11 m) than the previously published data. These results indicate that the thioether moiety has a crucial role in receptor activation. The results also show tolerance of the NK-1 receptor, but not NK-2 or NK-3, to cyclization of the C-terminal portion of the SP6-11 hexapeptide.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 48 条
[1]  
BITAN G, 1995, TETRAHEDRON, V51, P10513
[2]   New backbone cyclic substance P analogs [J].
Bitan, G ;
Behrens, S ;
Matha, B ;
Mashriki, Y ;
Hanani, M ;
Kessler, H ;
Gilon, C .
LETTERS IN PEPTIDE SCIENCE, 1995, 2 (3-4) :121-124
[3]   BUILDING UNITS FOR N-BACKBONE CYCLIC-PEPTIDES .1. SYNTHESIS OF PROTECTED N-(OMEGA-AMINOALKYLENE)AMINO ACIDS AND THEIR INCORPORATION INTO DIPEPTIDE UNITS [J].
BYK, G ;
GILON, C .
JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (21) :5687-5692
[4]  
BYK G, J MED CHEM IN PRESS
[5]   PREFERENTIAL CONFORMATION OF SUBSTANCE-P IN SOLUTION [J].
CHASSAING, G ;
CONVERT, O ;
LAVIELLE, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 154 (01) :77-85
[6]  
CHASSAING G, 1985, PEPTIDES 1984, P345
[7]   CONFORMATIONALLY RESTRICTED CYCLIC ANALOGS OF SUBSTANCE-P - INSIGHT INTO THE RECEPTOR-BINDING PROCESS [J].
DARMAN, PS ;
LANDIS, GC ;
SMITS, JR ;
HIRNING, LD ;
GULYA, K ;
YAMAMURA, HI ;
BURKS, TF ;
HRUBY, VJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 127 (02) :656-662
[8]   CONFORMATIONALLY CONSTRAINED TACHYKININ ANALOGS - POTENT AND HIGHLY SELECTIVE NEUROKININ NK-2 RECEPTOR AGONISTS [J].
DEAL, MJ ;
HAGAN, RM ;
IRELAND, SJ ;
JORDAN, CC ;
MCELROY, AB ;
PORTER, B ;
ROSS, BC ;
STEPHENSSMITH, M ;
WARD, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (22) :4195-4204
[9]   DISCOVERY OF A POTENT SUBSTANCE-P ANTAGONIST - RECOGNITION OF THE KEY MOLECULAR DETERMINANT [J].
DESAI, MC ;
LEFKOWITZ, SL ;
THADEIO, PF ;
LONGO, KP ;
SNIDER, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) :4911-4913
[10]  
DUPREAU G, 1987, EUR J PHARMACOL, V136, P401